These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

148 related articles for article (PubMed ID: 12030015)

  • 1. [Treatment with fluvoxamine against self-injury and aggressive behavior in autistic children].
    Yokoyama H; Hirose M; Haginoya K; Munakata M; Iinuma K
    No To Hattatsu; 2002 May; 34(3):249-53. PubMed ID: 12030015
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Clinical evaluation of treatment with fluvoxamine, a selective serotonin reuptake inhibitor in children with autistic disorder].
    Fukuda T; Sugie H; Ito M; Sugie Y
    No To Hattatsu; 2001 Jul; 33(4):314-8. PubMed ID: 11494573
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Venlafaxine and increased aggression in a female with autism.
    Marshall BL; Napolitano DA; McAdam DB; Dunleavy III JJ; Tessing JL; Varrell J
    J Am Acad Child Adolesc Psychiatry; 2003 Apr; 42(4):383-4. PubMed ID: 12649624
    [No Abstract]   [Full Text] [Related]  

  • 4. [Treatment of inter-specific aggression in cats with the selective serotonin reuptake inhibitor fluvoxamine. A case report].
    Sprauer S
    Tierarztl Prax Ausg K Kleintiere Heimtiere; 2012; 40(6):438-42. PubMed ID: 23242225
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Sertraline response in adults with mental retardation and autistic disorder.
    Hellings JA; Kelley LA; Gabrielli WF; Kilgore E; Shah P
    J Clin Psychiatry; 1996 Aug; 57(8):333-6. PubMed ID: 8778118
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A double-blind, placebo-controlled study of fluvoxamine in adults with autistic disorder.
    McDougle CJ; Naylor ST; Cohen DJ; Volkmar FR; Heninger GR; Price LH
    Arch Gen Psychiatry; 1996 Nov; 53(11):1001-8. PubMed ID: 8911223
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Near-fatal skin picking from delusional body dysmorphic disorder responsive to fluvoxamine.
    O'Sullivan RL; Phillips KA; Keuthen NJ; Wilhelm S
    Psychosomatics; 1999; 40(1):79-81. PubMed ID: 9989126
    [No Abstract]   [Full Text] [Related]  

  • 8. Paroxetine treatment of aggression and self-injury in persons with mental retardation.
    Davanzo PA; Belin TR; Widawski MH; King BH
    Am J Ment Retard; 1998 Mar; 102(5):427-37. PubMed ID: 9544340
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Two cases of adult Down syndrome treated with selective serotonin re-uptake inhibitor for behavior disorders].
    Hirayama T; Kobayashi T; Fujita T; Fujino O
    No To Hattatsu; 2004 Sep; 36(5):391-4. PubMed ID: 15461027
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Clinical efficacy of fluvoxamine and functional polymorphism in a serotonin transporter gene on childhood autism.
    Sugie Y; Sugie H; Fukuda T; Ito M; Sasada Y; Nakabayashi M; Fukashiro K; Ohzeki T
    J Autism Dev Disord; 2005 Jun; 35(3):377-85. PubMed ID: 16119478
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Serotonin 2A receptor gene polymorphism and clinical efficacy of fluvoxamine in children with autistic disorder].
    Sugie Y; Sugie H; Fukuda T; Ito M; Ohzeki T
    No To Hattatsu; 2003 Jan; 35(1):23-8. PubMed ID: 12607287
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Fluvoxamine treatment of a child with severe PDD: a single case study.
    Kauffmann C; Vance H; Pumariega AJ; Miller B
    Psychiatry; 2001; 64(3):268-77. PubMed ID: 11708052
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Trazodone for aggression in an adolescent with hydrocephalus.
    Mashiko H; Yokoyama H; Matsumoto H; Niwa S
    Psychiatry Clin Neurosci; 1996 Jun; 50(3):133-6. PubMed ID: 9201759
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Management of hyperactivity and other acting-out problems in patients with autism spectrum disorder.
    Aman MG
    Semin Pediatr Neurol; 2004 Sep; 11(3):225-8. PubMed ID: 15575418
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Trazodone reduced aggressive and self-injurious movements in a mentally handicapped male patient with autism.
    Gedye A
    J Clin Psychopharmacol; 1991 Aug; 11(4):275-6. PubMed ID: 1918430
    [No Abstract]   [Full Text] [Related]  

  • 16. Fluorine magnetic resonance spectroscopy measurement of brain fluvoxamine and fluoxetine in pediatric patients treated for pervasive developmental disorders.
    Strauss WL; Unis AS; Cowan C; Dawson G; Dager SR
    Am J Psychiatry; 2002 May; 159(5):755-60. PubMed ID: 11986128
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Studies on the adverse effects of fluvoxamine treatment in children with autistic disorder: correlation with genetic polymorphism in serotonin related genes].
    Sugie Y; Sugie H; Fukuda T; Ito M; Ohzeki T
    No To Hattatsu; 2003 May; 35(3):233-7. PubMed ID: 12755054
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Fluvoxamine for the treatment of anxiety disorders in children and adolescents. The Research Unit on Pediatric Psychopharmacology Anxiety Study Group.
    N Engl J Med; 2001 Apr; 344(17):1279-85. PubMed ID: 11323729
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Selective serotonin reuptake inhibitors (SSRIs) for autism spectrum disorders (ASD).
    Williams K; Brignell A; Randall M; Silove N; Hazell P
    Cochrane Database Syst Rev; 2013 Aug; (8):CD004677. PubMed ID: 23959778
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Safety of selective serotonin reuptake inhibitor antidepressants in children and adolescents].
    Bailly D
    Presse Med; 2006 Oct; 35(10 Pt 2):1507-15. PubMed ID: 17028514
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.